// App-Quantinova.ai

Su1751 : Genetic Markers of Medically-Refractory Ulcerative Colitis and Proximal Disease Extension on Long-Term Follow-up - a Genome-Wide Association Study

Researchers

Presenter

  • Jo Knight

Principal Investigators

  • Joanne M. Stempak

  • Ken Croitoru

  • Geoffrey C. Nguyen

  • Zane Cohen

  • Robin S. McLeod

  • Gordon R. Greenberg

  • A. Hillary Steinhart

  • Mark S. Silverberg

Medical Centers

  • Department of Paediatrics, Mount Sinai Hospital, Toronto, ON, Canada

  • Neuroscience Research, Centre of Addiction and Mental Health, Toronto, ON, Canada

  • B. Shine Rheumatology Unit, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion - Institute of Technology, Haifa, Israel

  • University of Toronto, Toronto, ON, Canada

  • Division of Gastroenterology, Mount Sinai Hospital, Toronto, Ontario, Canada

Locations

  • Canada

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • Plastin-3

  • Cluster of differentiation 95

  • G Protein-Coupled Receptor 65

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved